Your blog category
Amber Enterprises India Pvt. Ltd. has received a ‘Buy’ rating from PL Capital with a target price of Rs 9,782. Get the latest updates and analysis on the Indian stock markets.
India’s auto sales are expected to decline to a 12-month low in August as consumers wait for a potential GST rate cut announcement, impacting the start of the Great Indian Consumption season.
The Indian rupee has hit an all-time low against the US dollar. Understand the implications for the Indian economy, stock market, and your investments.
The Nifty India Defence Index has declined 21% from its 52-week high, with major defence stocks like HAL and Bharat Dynamics leading the fall. What are the key factors driving this trend, and what can investors expect in the near term?
Reliance Industries’ 48th annual general meeting brought significant announcements, including Jio’s impending IPO and the launch of Reliance Intelligence for AI infrastructure and services.
The NSE Nifty 50 and BSE Sensex declined for three days in a row as Reliance Industries emerged as the top dragger. Get the latest updates from the Indian stock markets including Nifty levels, Q1 results, and major corporate actions affecting investor sentiment.
Get the latest updates from Reliance AGM 2025, including Jio IPO announcement, Reliance Intelligence, and ambitious green energy plans.
Indian refiners are planning to reduce their purchases of Russian crude oil in the coming weeks, amid increasing pressure from the US to cut ties with Moscow. Get the latest updates on the Indian energy sector and its implications on the economy.
The Indian stock market witnessed a sharp decline on Tuesday, with the NSE Nifty 50 falling below 24,800 and the BSE Sensex losing over 700 points. We analyze the key factors behind this fall and what it means for investors.
Anlon Healthcare Ltd.’s initial public offering (IPO) was fully subscribed on the first day of its opening, with retail investors showing strong interest. The IPO, worth Rs 121.03 crore, is expected to bring new opportunities for investors in the pharmaceutical sector.